Industry Analysts Just Upgraded Their Immunomedics, Inc. (NASDAQ:IMMU) Revenue Forecasts By 16%

Industry Analysts Just Upgraded Their Immunomedics, Inc. (NASDAQ:IMMU) Revenue Forecasts By 16%Immunomedics, Inc. (NASDAQ:IMMU) shareholders will have a reason to smile today, with the analysts making substantial…

from Yahoo Finance https://ift.tt/3dHWzbl

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *